This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Sunshine Lake Pharma Co., Ltd., North & South Brother Pharmacy Investment Company Limited. Active years: 2019-2021.
Company Filing History:
2 out of 119 
1 out of 10 
Years Active: 2019-2021
Title: Junwen Wu: Innovator in Nitrogenous Tricyclic Compounds
Introduction
Junwen Wu is a notable inventor based in Dongguan, China. He has made significant contributions to the field of medicinal chemistry, particularly through his work on nitrogenous tricyclic compounds. With a total of 3 patents, his innovations are paving the way for new treatments in medicine.
Latest Patents
Wu's latest patents include groundbreaking work on nitrogenous tricyclic compounds and their applications in medicine. One of his patents focuses on a novel nitrogenous tricyclic compound that acts as an FXR active regulator. This compound, along with its various forms such as stereoisomers and prodrugs, is designed for use in the manufacture of drugs aimed at treating diseases regulated by FXR. Another patent describes a nitrogen-containing tricyclic compound that serves as a modulator of FXR, highlighting its potential in treating conditions mediated by this receptor. Both patents also detail pharmaceutical compositions containing these compounds and methods for their administration.
Career Highlights
Throughout his career, Junwen Wu has worked with prominent companies in the pharmaceutical industry. He has been associated with Sunshine Lake Pharma Co., Ltd. and North & South Brother Pharmacy Investment Company Limited. His work in these organizations has allowed him to further develop his innovative ideas and contribute to the advancement of medical treatments.
Collaborations
Wu has collaborated with several professionals in his field, including Xiaojun Wang and Xinye Yang. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of new pharmaceutical compounds.
Conclusion
Junwen Wu's contributions to the field of medicinal chemistry through his patents on nitrogenous tricyclic compounds demonstrate his commitment to advancing healthcare solutions. His work continues to inspire future innovations in medicine.